YHB Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.4M Buy
9,488
+972
+11% +$993K 0.73% 35
2026
Q1
$7.83M Buy
8,516
+488
+6% +$495K 0.56% 51
2025
Q4
$8.63M Buy
8,028
+577
+8% +$552K 0.6% 43
2025
Q3
$5.68M Buy
7,451
+312
+4% +$232K 0.42% 64
2025
Q2
$5.56M Buy
7,139
+271
+4% +$211K 0.43% 62
2025
Q1
$5.67M Buy
6,868
+575
+9% +$478K 0.47% 56
2024
Q4
$4.86M Buy
6,293
+901
+17% +$746K 0.4% 62
2024
Q3
$4.78M Buy
5,392
+746
+16% +$671K 0.4% 66
2024
Q2
$4.21M Buy
4,646
+4,015
+636% +$3.21M 0.36% 68
2024
Q1
$491K Sell
631
-22
-3% -$15.7K 0.04% 191
2023
Q4
$381K Buy
653
+44
+7% +$25.7K 0.04% 208
2023
Q3
$327K Buy
609
+32
+6% +$16.5K 0.03% 218
2023
Q2
$271K Sell
577
-1,347
-70% -$565K 0.03% 235
2023
Q1
$661K Buy
1,924
+35
+2% +$11.8K 0.07% 170
2022
Q4
$691K Sell
1,889
-44
-2% -$15.6K 0.07% 163
2022
Q3
$625K Hold
1,933
0.07% 172
2022
Q2
$627K Hold
1,933
0.07% 172
2022
Q1
$554K Buy
1,933
+104
+6% +$26.8K 0.05% 191
2021
Q4
$505K Hold
1,829
0.04% 211
2021
Q3
$423K Buy
1,829
+45
+3% +$11.1K 0.04% 210
2021
Q2
$410K Sell
1,784
-16
-0.9% -$3.21K 0.03% 218
2021
Q1
$341K Hold
1,800
0.03% 228
2020
Q4
$304K Buy
1,800
+32
+2% +$4.78K 0.03% 233
2020
Q3
$262K Buy
+1,768
New +$274K 0.03% 229
2016
Q1
Sell
-2,669
Closed -$225K 158
2015
Q4
$225K Buy
2,669
+159
+6% +$13.2K 0.05% 151
2015
Q3
$210K Buy
2,510
+50
+2% +$4.22K 0.05% 152
2015
Q2
$205K Buy
+2,460
New +$187K 0.04% 165

Other funds holding LLY

YHB Investment Advisors's LLY Position: Q2 2026 in Review

YHB Investment Advisors increased its Eli Lilly (LLY) stake by 11% in Q2 2026, buying an estimated $993K and bringing the position to 9,488 shares worth $11.4M. The position accounts for 0.73% of the portfolio, ranked #35.

YHB Investment Advisors first reported a position in LLY in Q2 2015 and has held it in 27 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • YHB Investment Advisors held 9,488 shares of Eli Lilly worth $11.4M as of Q2 2026.
  • YHB Investment Advisors bought 972 Eli Lilly shares in Q2 2026, an estimated $993K.
  • Eli Lilly made up 0.73% of YHB Investment Advisors's portfolio in Q2 2026, its #35 holding.
  • YHB Investment Advisors first reported a position in Eli Lilly in Q2 2015 and has held it in 27 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on YHB Investment Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.